Angioimmunoblastic lymphadenopathy.
Azevedo SJ, Yunis AA.
Am J Hematol. 1985 Nov;20(3):301-12. doi: 10.1002/ajh.2830200314.
Angioimmunoblastic lymphadenopathy.
Su WP.
Dermatol Clin. 1985 Oct;3(4):759-68.
Angioimmunoblastic lymphadenopathy: comprehensive review.
Levey IL.
Cancer Invest. 1987;5(6):633-47. doi: 10.3109/07357908709020323.
[Angioimmunoblastic lymphadenopathy with dysproteinemia].
Marchi L, Frascisco M, Mairano D, Biarese V, Andrione P, Manachino D, Lovisetto P.
Recenti Prog Med. 1989 Jun;80(6):326-32.
Angioimmunoblastic lymphadenopathy with dysproteinemia: emphasis on pathogenesis and treatment.
Sallah S, Gagnon GA.
Acta Haematol. 1998;99(2):57-64. doi: 10.1159/000040811.
Angioimmunoblastic lymphadenopathy.
Emery P, Panayi GS.
Ann Rheum Dis. 1988 Jan;47(1):84. doi: 10.1136/ard.47.1.84-a.
[Angioimmunoblastic lymphadenopathy].
Campo E.
Med Clin (Barc). 1990 Jun 16;95(3):97-9.
Angioimmunoblastic lymphadenopathy with dysproteinemia.
Freter CE, Cossman J.
Semin Oncol. 1993 Dec;20(6):627-35.
Angioimmunoblastic lymphadenopathy with dysproteinemia: report of a case in infancy with review of literature.
de Terlizzi M, Toma MG, Santostasi T, Colella R, Ceci A, De Benedictis G.
Pediatr Hematol Oncol. 1989;6(1):37-44. doi: 10.3109/08880018909014579.
Salazosulfapyridine-induced angioimmunoblastic lymphadenopathy.
Nakano A, Hatta K, Kobashi Y, Goto M, Imanaka T.
Intern Med. 1996 Nov;35(11):894-7. doi: 10.2169/internalmedicine.35.894.
